Residents/Fellows Awards, Honors & Publications
Recent Honors, Awards, Appointments and Publications
(Listed by date)
(July 2020) Drs. Catherine Beni, Research Resident, Mohini Dasari, (R4) Alison Haruta, (R4) and David Miranda, (R4), Joshua Rosen, Research Resident, were nominated for the Harborview Medical Center "Outstanding Consultant of the Year Award" for the 2019-20 academic year by the University of Washington Department of Emergency Medicine Residency Program.
Drs. Christopher Little, (R2) and Matias Czerwonko-Pupi, (R3), were nominated for the University of Washington Medical Center "Outstanding Consultant of the Year Award" for the 2019-20 academic year by the University of Washington Department of Emergency Medicine Residency Program.
Dr. Francys Verdial, General Surgery Chief Resident, published two articles: "Multidisciplinary Team-Based Management of Incidentally Detected Lung Nodules," published in CHEST Journal, April 2020.
Over 1.5 million Americans are diagnosed with an incidentally detected lung nodule each year. While practice guidelines attempt to balance the benefit of early detection of lung cancer with the risks of diagnostic testing, adherence to these guidelines is low. Our research group sought to better understand lung nodule care delivery in the context of a multidisciplinary specialty clinic. Weasked, "What is the rate of guideline adherence in our multidisciplinary lung nodule clinic and when do we deviate from guidelines? Can our experience be used as a model for navigating complex care decisions?" We found that guideline-concordant care was recommended in approximately two-thirds of patients and that the most common reason for recommending guideline-discordant care was concern for two different diagnoses that would each benefit from early detection and treatment. Our data suggest that a multidisciplinary nodule clinic may serve as a system-level intervention to promote guideline-concordant care, while also providing a multidisciplinary basis by which to deviate from guidelines to address the needs of this heterogeneous patient population.
"Safety and Costs of Endobronchial Ultrasound-Guided Nodal Aspiration and Mediastinoscopy," published in CHEST Journal, March 2020.
There remains debate over the best invasive diagnostic modality for evaluating mediastinal nodal pathology and stage lung cancer. We compared the risks and costs of endobronchial ultrasound (EBUS)-guided nodal aspiration and mediastinoscopy in a large national cohort. We found that, when performed as isolated procedures, EBUS is associated with lower risks and costs compared with mediastinoscopy. In this study, we focused on one side of the coin, risk and cost, to better understand how these procedures compare in these two important areas in the real world. Future studies comparing the effectiveness of EBUS versus ediastinoscopy in the community at large will help determine which procedure is superior or if trade-offs exist.